Active Ingredients

Advanced Search

Side Effect Reporting

Search Medicine Database

Home Medicines Active Ingredients Companies DHPC Advanced Search Side Effect Reporting

Home
Active Ingredients
Durvalumab

Durvalumab

Medicine

Status

Monitoring

SPC

PIL

XPIL

Legal Category

Active Ingredient(s)

Company

IMFINZI 50 mg/mL concentrate for solution for infusion

No Recent Update

No

A

AstraZeneca Pharmaceuticals (Ireland) DAC

Brought to you by

About

Help
About
Contact Us

Legal

Privacy Statement
Terms & Conditions
Accessibility

Search

Medicines
Active Ingredients
Companies

Award

Designed by eConcept Web Solutions

Direct Healthcare Professional Communications

This medicine and its document have not been updated in the last 30 days.

Product subject to medical prescription which may not be renewed (A)